Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Apr 24;24(7):991-1000.
doi: 10.1097/qad.0b013e328336e98b.

Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men

Moupali Das  1 , Deirdre Santos, Tim Matheson, Glenn-Milo Santos, Priscilla Chu, Eric Vittinghoff, Steve Shoptaw, Grant N Colfax
Affiliations
Clinical Trial

Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men

Moupali Das et al. AIDS. .

Abstract

Objective: To determine whether actively using, methamphetamine (meth)-dependent men who have sex with men (msm) could be enrolled and retained in a pharmacologic intervention trial, and the degree to which participants would adhere to study procedures, including medication adherence. study design: phase ii randomized, double-blind trial of bupropion vs. placebo.

Methods: Thirty meth-dependent, sexually active MSM were randomized to receive daily bupropion XL 300 mg or placebo for 12 weeks. Participants received weekly substance use counseling, provided weekly urine specimens, and completed monthly audio-computer assisted self-interview (ACASI) behavioral risk assessments. Adherence was measured by medication event monitoring systems (MEMS) caps (the number of distinct MEMS cap openings divided by the number of expected doses) and self-report.

Results: Ninety percent completed the trial: 89% of monthly ACASIs were completed, 81% of study visits were attended, and 81% of urine samples were collected. Adherence by MEMS cap was 60% and by self-report was 81% and did not differ significantly by treatment assignment. The median number of positive urine samples was 5.5 out of a possible 11 (50%). Participants in both arms reported similar declines in the median number of sex partners (P = 0.52). No serious adverse events occurred and there were no significant differences in adverse events by treatment assignment (P = 0.11).

Conclusions: It is feasible to enroll and retain actively using, meth-dependent MSM in a pharmacologic intervention. Bupropion was well tolerated. Study participation and retention rates were high, however, study drug medication adherence was only moderate. Findings support a larger trial with improved adherence support to evaluate the efficacy of bupropion and other pharmacologic interventions for meth dependence in this population.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Participant flow diagram
F/U, follow-up.
Fig. 2
Fig. 2
Longitudinal trends of the percent positive urine meth screens by treatment assignment.
See this image and copyright information in PMC

References

    1. Increasing morbidity and mortality associated with abuse of methamphetamine: United States, 1991–1994. MMWR Morb Mortal Wkly Rep. 1995;44:882–886. - PubMed
    1. Treatment Episode Data Set (TEDS) Highlights: 2003. National admissions to substance abuse treatment services. DASIS Series: S-27. DHHS Publication No. (SMA) 05–4043. 2005. http://www.oas.samhsa.gov/2k5/meth/meth.htm.
    1. Roberts DL, Ball J. Amphetamine and methamphetamine emergency department visits, 1995–2002 The drug abuse warning network. The DAWN report. Jul, 2004. [Accessed 22 February 2007]. http://www.oas.samh-sa.gov/2k4amphetamines.pdf.
    1. Brecht ML, Greenwell L, Anglin MD. Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992–2002) J Subst Abuse Treat. 2005;29:295–306. - PubMed
    1. Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry. 2005;13:141–154. - PubMed

Publication types